BackHealth Catalyst Overview

Health Catalyst Receivables

Track Health Catalyst's receivables ($42M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$41.90M
38.72% YoYΔ $-26.48M vs prior year quarter

Peer trimmed avg / median

Loading

Health Catalyst Receivables History

Loading

Health Catalyst vs. peers: Receivables Comparison

Loading

Health Catalyst Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Health Catalyst (HCAT) FAQ

Health Catalyst (HCAT) currently reports a receivables of $42M as of June 2026. That compares with $68M in the prior-year period — down 38.7% year over year. Use the charts on this page to explore Health Catalyst's receivables history and peer comparisons.

Health Catalyst's receivables decreased from $68M to $42M — a 38.7% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Health Catalyst reported $42M in receivables as of June 2026. That compares with $68M in the prior-year period — down 38.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $42M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Health Catalyst, and consider following HCAT for alerts when major investors trade the stock.

Health Catalyst is classified in the Healthcare sector. On receivables, it currently shows $42M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing HCAT with unrelated industries.